4.69
price up icon0.86%   0.04
after-market Dopo l'orario di chiusura: 4.52 -0.17 -3.62%
loading
Precedente Chiudi:
$4.65
Aprire:
$4.66
Volume 24 ore:
11,039
Relative Volume:
0.11
Capitalizzazione di mercato:
$5.47M
Reddito:
-
Utile/perdita netta:
$-7.03M
Rapporto P/E:
-0.5262
EPS:
-8.9134
Flusso di cassa netto:
$-8.20M
1 W Prestazione:
+2.18%
1M Prestazione:
+19.64%
6M Prestazione:
-18.86%
1 anno Prestazione:
+14.67%
Intervallo 1D:
Value
$4.30
$4.7174
Intervallo di 1 settimana:
Value
$4.09
$4.9799
Portata 52W:
Value
$2.90
$11.96

Endra Life Sciences Inc Stock (NDRA) Company Profile

Name
Nome
Endra Life Sciences Inc
Name
Telefono
734-335-0468
Name
Indirizzo
3600 GREEN COURT, ANN ARBOR, MI
Name
Dipendente
16
Name
Cinguettio
@endralifesci
Name
Prossima data di guadagno
2026-03-30
Name
Ultimi documenti SEC
Name
NDRA's Discussions on Twitter

Compare NDRA vs TMO, DHR, IDXX, A, WAT

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
NDRA icon
NDRA
Endra Life Sciences Inc
4.69 5.47M 0 -7.03M -8.20M -8.9134
TMO icon
TMO
Thermo Fisher Scientific Inc
491.46 182.57B 44.56B 6.72B 6.29B 17.74
DHR icon
DHR
Danaher Corp
191.12 135.26B 24.57B 3.60B 5.26B 5.051
IDXX icon
IDXX
Idexx Laboratories Inc
569.55 45.24B 4.30B 1.06B 1.04B 13.08
A icon
A
Agilent Technologies Inc
115.48 32.63B 7.07B 1.29B 993.00M 4.5355
WAT icon
WAT
Waters Corp
304.24 29.85B 3.17B 642.63M 516.49M 10.77

Endra Life Sciences Inc Borsa (NDRA) Ultime notizie

pulisher
Apr 04, 2026

ENDRA Life Sciences Inc.Common Stock (NQ: NDRA - FinancialContent

Apr 04, 2026
pulisher
Apr 02, 2026

NDRA Stock Price, Quote & Chart | ENDRA LIFE SCIENCES INC (NASDAQ:NDRA) - ChartMill

Apr 02, 2026
pulisher
Mar 31, 2026

ENDRA Life Sciences Inc reports results for the quarter ended September 30Earnings Summary - TradingView

Mar 31, 2026
pulisher
Mar 31, 2026

ENDRA (NDRA) Optimistic About TAEUS Technology's Potential - GuruFocus

Mar 31, 2026
pulisher
Mar 31, 2026

ENDRA Life Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Mar 31, 2026
pulisher
Mar 31, 2026

ENDRA Life Sciences (NASDAQ: NDRA) flags going-concern risk and pivots to digital asset treasury - Stock Titan

Mar 31, 2026
pulisher
Mar 31, 2026

ENDRA Life Sciences | 8-K: ENDRA Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - Moomoo

Mar 31, 2026
pulisher
Mar 31, 2026

ENDRA Life Sciences Q4 net loss narrows - TradingView

Mar 31, 2026
pulisher
Mar 31, 2026

ENDRA Life Sciences (NASDAQ: NDRA) cuts 2025 operating costs sharply - Stock Titan

Mar 31, 2026
pulisher
Mar 31, 2026

ENDRA Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - Business Wire

Mar 31, 2026
pulisher
Mar 31, 2026

Day Trade: Whats the MACD signal for ENDRA Life Sciences Inc2026 Market Overview & Daily Entry Point Alerts - baoquankhu1.vn

Mar 31, 2026
pulisher
Mar 30, 2026

Movement Recap: Does ENDRA Life Sciences Inc outperform in volatile marketsWeekly Market Summary & Accurate Entry/Exit Alerts - baoquankhu1.vn

Mar 30, 2026
pulisher
Mar 29, 2026

ENDRA Life Sciences (NDRA) Expected to Announce Earnings on Monday - National Today

Mar 29, 2026
pulisher
Mar 27, 2026

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Mar 27, 2026
pulisher
Mar 26, 2026

NDRA Ignites: 20% Surge Signals Strategic Overhaul as Capital Hunt for Micro-Cap Alphas - Bitget

Mar 26, 2026
pulisher
Mar 26, 2026

12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Mar 26, 2026
pulisher
Mar 26, 2026

ENDRA Life Sciences Explores Strategic Alternatives Amid Restructuring - The Globe and Mail

Mar 26, 2026
pulisher
Mar 25, 2026

ENDRA Life Sciences explores strategic alternatives By Investing.com - in.investing.com

Mar 25, 2026
pulisher
Mar 25, 2026

Speculation Alert: PRSO, ITOC, NDRA, BZAI Small-Cap Momentum Builds – More Names Inside - FinancialContent

Mar 25, 2026
pulisher
Mar 25, 2026

ENDRA Life Sciences Initiates Review of Strategic Alternatives to Maximize Shareholder Value - BioSpace

Mar 25, 2026
pulisher
Mar 25, 2026

Strategic options review launched by ENDRA Life Sciences (Nasdaq: NDRA) - Stock Titan

Mar 25, 2026
pulisher
Mar 25, 2026

ENDRA Life Sciences explores strategic alternatives - Investing.com

Mar 25, 2026
pulisher
Mar 25, 2026

ENDRA (NDRA) Explores Strategic Options to Enhance Shareholder V - GuruFocus

Mar 25, 2026
pulisher
Mar 25, 2026

ENDRA Life Sciences Inc. Initiates Review of Strategic Alternatives to Maximize Shareholder Value - marketscreener.com

Mar 25, 2026
pulisher
Mar 24, 2026

ENDRA Life Sciences Inc announced that its Board of Directors has initiated a strategic review process aimed at a comprehensive assessment of the company’s future development pathways. - Bitget

Mar 24, 2026
pulisher
Mar 23, 2026

ENDRA Life Sciences (NDRA) Expected to Announce Quarterly Earnings on Monday - Defense World

Mar 23, 2026
pulisher
Mar 22, 2026

If You Invested $1,000 in Endra Life Sciences Inc (NDRA) - Stock Titan

Mar 22, 2026
pulisher
Mar 20, 2026

Tech Rally: Is ENDRA Life Sciences Inc being accumulated by smart money2026 Patterns & Reliable Price Action Trade Plans - baoquankhu1.vn

Mar 20, 2026
pulisher
Mar 19, 2026

Stocks Under $10: IBRX, VTIX, NDRA, SMX2026 Watch Now! - openPR.com

Mar 19, 2026
pulisher
Mar 19, 2026

Stocks Under $10: IBRX, VTIX, NDRA, SMX – 2026 Watch Now! - The Norfolk Daily News

Mar 19, 2026
pulisher
Mar 19, 2026

IBRX, VTIX, NDRA, SMX – 2026 Watch Now! - FinancialContent

Mar 19, 2026
pulisher
Mar 18, 2026

ENDRA Life Sciences (NASDAQ: NDRA) - MarketScreener

Mar 18, 2026
pulisher
Mar 17, 2026

ENDRA Life Sciences (NASDAQ: NDRA): Medical Diagnostic Play in the $100B+MASH+GLP-1 Healthcare Boom - openPR.com

Mar 17, 2026
pulisher
Mar 17, 2026

ENDRA Life Sciences (NASDAQ: NDRA): Medical Diagnostic Play In The $100B+MASH+GLP-1 Healthcare Boom - Mena FN

Mar 17, 2026
pulisher
Mar 10, 2026

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Mar 10, 2026
pulisher
Mar 09, 2026

User - The Chronicle-Journal

Mar 09, 2026
pulisher
Mar 09, 2026

ENDRA Life Sciences (NASDAQ: NDRA): The GLP-1 Healthcare Boom Offering Tremendous Opportunity Watch HIMS, ANTX, ATAI, PURR Now! - Barchart.com

Mar 09, 2026
pulisher
Mar 09, 2026

FinancialContentFavorable Results on Liver Device for Long-Term Monitoring of Metabolic Dysfunction-Associated Steatotic Liver Disease Affecting 30% of Adults: ENDRA Life Sciences (Nasdaq: NDRA) - FinancialContent

Mar 09, 2026
pulisher
Mar 09, 2026

Strong Clinical Results for Breakthrough Liver Diagnostic Platform; ENDRA Life Sciences (N A S D A Q: NDRA) $NDRA - FinancialContent

Mar 09, 2026
pulisher
Mar 09, 2026

Favorable Results on Liver Device for Long-Term Monitoring of Metabolic Dysfunction-Associated Steatotic Liver Disease Affecting 30% of Adults: ENDRA Life Sciences (Nasdaq: NDRA) - Barchart

Mar 09, 2026
pulisher
Mar 09, 2026

Favorable Results on Liver Device for Long-Term Monitoring - openPR.com

Mar 09, 2026
pulisher
Mar 07, 2026

Will ENDRA Life Sciences Inc. stock outperform growth indexesWeekly Trend Summary & Reliable Entry Point Alerts - Naître et grandir

Mar 07, 2026
pulisher
Mar 04, 2026

[Form 4] ENDRA Life Sciences Inc. Insider Trading Activity - Stock Titan

Mar 04, 2026
pulisher
Mar 03, 2026

NDRA's TAEUS system Reaches MRI-Comparable Accuracy in Liver Imaging - Bitget

Mar 03, 2026
pulisher
Mar 03, 2026

NDRA's TAEUS Device Achieves MRI-Level Liver Imaging Precision - TradingView

Mar 03, 2026
pulisher
Feb 28, 2026

NDRA Should I Buy - Intellectia AI

Feb 28, 2026
pulisher
Feb 27, 2026

NDRA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Feb 27, 2026
pulisher
Feb 27, 2026

Stocks in the News: ALBT, NDRA, CURX, HCTIAI, Clinical Milestones Drive Market Surges - marketscreener.com

Feb 27, 2026
pulisher
Feb 26, 2026

ENDRA’s TAEUS® Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Le - PharmiWeb.com

Feb 26, 2026
pulisher
Feb 26, 2026

Endra Life Sciences (NDRA) Announces Positive Trial Results for Liver Device - GuruFocus

Feb 26, 2026
pulisher
Feb 26, 2026

ENDRA’s TAEUS® Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Level Results at the Point of Patient Care - Yahoo Finance

Feb 26, 2026

Endra Life Sciences Inc Azioni (NDRA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
DGX DGX
$198.02
price up icon 0.17%
LH LH
$273.72
price up icon 0.36%
MTD MTD
$1,259.94
price down icon 1.11%
IQV IQV
$173.26
price up icon 0.50%
$207.98
price up icon 2.35%
WAT WAT
$304.24
price up icon 1.45%
Capitalizzazione:     |  Volume (24 ore):